{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:58:58Z","timestamp":1793066338173,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Calpainopathies, including limb-girdle muscular dystrophy recessive type 1 (LGMD R1) and the rare dominant type 4 (LGMD D4), are genetic neuromuscular disorders caused by pathogenic variants in the\n                      <jats:italic>CAPN3<\/jats:italic>\n                      gene, which encodes calpain-3, a muscle-specific cysteine protease. This protein plays a crucial role in muscle remodelling, calcium homeostasis, and myogenesis regulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>\n                      LGMD R1, the most common form of LGMD, is characterized by progressive, symmetrical muscle weakness primarily affecting the shoulder and pelvic girdles, with an onset ranging from childhood to adulthood. It affects about 1 in 100,000 individuals. The clinical spectrum is wide, with three main phenotypes: pelvifemoral myopathy, scapulohumeral myopathy, and isolated hyperCKemia. LGMD D4 is characterized generally by a milder phenotype with variable but frequent axial muscle involvement. Diagnostic algorithm include serum CK levels dosage, muscle imaging, and sometimes a muscle biopsy, with definitive diagnosis confirmed by\n                      <jats:italic>CAPN3<\/jats:italic>\n                      gene testing. Calpainopathies have no cure and care is focused on physiotherapy, management of muscle contractures, moderate physical activity, and orthosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The newly established French National Diagnosis and Care Protocol (NDCP) aim to standardize the diagnosis and care of calpainopathies. The protocol emphasizes early diagnosis, personalized patient care, genetic assessment and prevention of disease progression. This initiative aims to reduce diagnostic delays and improve patient outcomes through a harmonized multidisciplinary approach, informed by the latest clinical and research expertise.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04279-5","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:28:48Z","timestamp":1772202528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["French National Protocol for Diagnosis and Care of Calpainopathy (LGMD R1\/LGMD D4): consensus guidelines for clinical practice"],"prefix":"10.1186","volume":"21","author":[{"given":"Gianmarco","family":"Severa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Souvannanorath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Tahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Alimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abderhmane","family":"Slioui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Salort-Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Leturcq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Streichenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9onard","family":"Feasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Nadaj-Pakleza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Tard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7871-8600","authenticated-orcid":false,"given":"Edoardo","family":"Malfatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"1","key":"4279_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0092-8674(95)90368-2","volume":"81","author":"I Richard","year":"1995","unstructured":"Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 1995;81(1):27\u201340.","journal-title":"Cell"},{"issue":"Pt 4","key":"4279_CR2","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/brain\/awh408","volume":"128","author":"A S\u00e1enz","year":"2005","unstructured":"S\u00e1enz A, Leturcq F, Cobo AM, Poza JJ, Ferrer X, Otaegui D, et al. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain. 2005;128(Pt 4):732\u201342.","journal-title":"Brain"},{"key":"4279_CR3","unstructured":"Angelini C. Calpainopathy. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2025 Nov 12]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1313\/"},{"issue":"2","key":"4279_CR4","first-page":"54","volume":"27","author":"J Schessl","year":"2008","unstructured":"Schessl J, Walter MC, Schreiber G, Schara U, M\u00fcller CR, Lochm\u00fcller H, et al. Phenotypic variability in siblings with calpainopathy (LGMD2A). Acta Myol. 2008;27(2):54\u20138.","journal-title":"Acta Myol"},{"issue":"12","key":"4279_CR5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/sj.ejhg.5200888","volume":"10","author":"F de Paula","year":"2002","unstructured":"de Paula F, Vainzof M, Passos-Bueno MR, de C\u00e1ssia M, Pavanello R, Matioli SR, Anderson VB. Clinical variability in calpainopathy: what makes the difference? Eur J Hum Genet. 2002;10(12):825\u201332.","journal-title":"Eur J Hum Genet"},{"key":"4279_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jocn.2018.04.025","volume":"53","author":"JM Martinez-Thompson","year":"2018","unstructured":"Martinez-Thompson JM, Moore SA, Liewluck T. A novel CAPN3 mutation in late-onset limb-girdle muscular dystrophy with early respiratory insufficiency. J Clin Neurosci. 2018;53:229\u201331.","journal-title":"J Clin Neurosci"},{"issue":"6","key":"4279_CR7","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/acn3.70049","volume":"12","author":"SM Hunn","year":"2025","unstructured":"Hunn SM, Alfano LN, Jones A, Butler A, Lowes LP, Iammarino MA, et al. Clinical Trial Readiness in Limb Girdle Muscular Dystrophy R1 (LGMDR1): A GRASP Consortium Study. Ann Clin Transl Neurol. 2025;12(6):1179\u201386.","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"4279_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/acn3.287","volume":"3","author":"I Richard","year":"2016","unstructured":"Richard I, Hogrel JY, Stockholm D, Payan CAM, Fougerousse F, Calpainopathy Study Group. Natural history of LGMD2A for delineating outcome measures in clinical trials. Ann Clin Transl Neurol. 2016;3(4):248\u201365.","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"4279_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/mus.24682","volume":"52","author":"M Fanin","year":"2015","unstructured":"Fanin M, Angelini C. Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: The yield and the pitfalls. Muscle Nerve. 2015;52(2):163\u201373.","journal-title":"Muscle Nerve"},{"key":"4279_CR10","doi-asserted-by":"publisher","first-page":"105786","DOI":"10.1016\/j.nmd.2025.105786","volume":"53","author":"B Est\u00e9vez-Arias","year":"2025","unstructured":"Est\u00e9vez-Arias B, Segarra-Casas A, Romo L, Polavarapu K, O\u2019Heir E, Singer-Berk M, et al. 490PA recurrent non-coding 3\u2019UTR variant as a hidden second hit in 11 families with CAPN3-related limb girdle muscular dystrophy. Neuromuscul Disord. 2025;53:105786.","journal-title":"Neuromuscul Disord"},{"key":"4279_CR11","doi-asserted-by":"publisher","first-page":"9301465","DOI":"10.1155\/humu\/9301465","volume":"2025","author":"T Krag","year":"2025","unstructured":"Krag T, Nasho E, Brady L, Verebi C, Leturcq F, Malfatti E, et al. Variants in CAPN3 causing autosomal dominant limb-girdle muscular dystrophy combined with calpain-3 deficiency. Hum Mutat. 2025;2025:9301465.","journal-title":"Hum Mutat"},{"issue":"12","key":"4279_CR12","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/acn3.649","volume":"5","author":"BRR Nallamilli","year":"2018","unstructured":"Nallamilli BRR, Chakravorty S, Kesari A, Tanner A, Ankala A, Schneider T, et al. Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. Ann Clin Transl Neurol. 2018;5(12):1574\u201387.","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"4279_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/mus.25970","volume":"57","author":"JM Martinez-Thompson","year":"2018","unstructured":"Martinez-Thompson JM, Niu Z, Tracy JA, Moore SA, Swenson A, Wieben ED, et al. Autosomal dominant calpainopathy due to heterozygous CAPN3 C.643_663del21. Muscle Nerve. 2018;57(4):679\u201383.","journal-title":"Muscle Nerve"},{"issue":"6","key":"4279_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/nan.12624","volume":"46","author":"M Cerino","year":"2020","unstructured":"Cerino M, Campana-Salort E, Salvi A, Cintas P, Renard D, Juntas Morales R, et al. Novel CAPN3 variant associated with an autosomal dominant calpainopathy. Neuropathol Appl Neurobiol. 2020;46(6):564\u201378.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"4279_CR15","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1002\/acn3.51193","volume":"7","author":"M Cerino","year":"2020","unstructured":"Cerino M, Bartoli M, Riccardi F, Le Goanvic B, Blanck V, Salvi A, et al. Autosomal dominant segregation of CAPN3 c.598_612del15 associated with a mild form of calpainopathy. Ann Clin Transl Neurol. 2020;7(12):2538\u201340.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"4279_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3892\/etm.2024.12385","volume":"27","author":"B Mao","year":"2024","unstructured":"Mao B, Yang J, Zhao X, Jia X, Shi X, Zhao L, et al. Identification and functional characterization of a novel heterozygous splice\u2013site mutation in the calpain 3 gene causes rare autosomal dominant limb\u2013girdle muscular dystrophy. Exp Ther Med. 2024;27(3):97.","journal-title":"Exp Ther Med"},{"key":"4279_CR17","doi-asserted-by":"publisher","first-page":"1437859","DOI":"10.3389\/fgene.2024.1437859","volume":"15","author":"S Massucco","year":"2024","unstructured":"Massucco S, Fossa P, Fiorillo C, Faedo E, Gemelli C, Barresi R, et al. Case report: A single novel calpain 3 gene variant associated with mild myopathy. Front Genet. 2024;15:1437859.","journal-title":"Front Genet"},{"issue":"2","key":"4279_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/nan.12663","volume":"47","author":"L Gonz\u00e1lez-Mera","year":"2021","unstructured":"Gonz\u00e1lez-Mera L, Ravenscroft G, Cabrera-Serrano M, Ermolova N, Dom\u00ednguez-Gonz\u00e1lez C, Arteche-L\u00f3pez A, et al. Heterozygous CAPN3 missense variants causing autosomal-dominant calpainopathy in seven unrelated families. Neuropathol Appl Neurobiol. 2021;47(2):283\u201396.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4279_CR19","doi-asserted-by":"crossref","unstructured":"Malfatti E, Richard I. [Calpainopathies: state of the art and therapeutic perspectives]. Med Sci (Paris). 2020;36 Hors s\u00e9rie n\u00b0 2:17\u201321.","DOI":"10.1051\/medsci\/2020244"},{"issue":"Pt 8","key":"4279_CR20","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1093\/brain\/aww133","volume":"139","author":"J Vissing","year":"2016","unstructured":"Vissing J, Barresi R, Witting N, Van Ghelue M, Gammelgaard L, Bindoff LA, et al. A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy. Brain. 2016;139(Pt 8):2154\u201363.","journal-title":"Brain"},{"key":"4279_CR21","doi-asserted-by":"crossref","unstructured":"Richard I, Simental E, Staelens C, Eng C, Malfatti E. Le registre national des calpa\u00efnopathies. Les Cahiers de Myologie. 2022;(25):40\u20131.","DOI":"10.1051\/myolog\/202225008"},{"key":"4279_CR22","doi-asserted-by":"crossref","unstructured":"Lostal W, Urtizberea JA, Richard I; Calpain 3 Study Group. 233rd ENMC International Workshop: Clinical trial readiness for calpainopathies, Naarden, The Netherlands, 15\u201317 September 2017. Neuromuscul Disord. 2018;28(6):540-549.","DOI":"10.1016\/j.nmd.2018.03.010"},{"issue":"Pt 3","key":"4279_CR23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1042\/bj3280721","volume":"328","author":"H Sorimachi","year":"1997","unstructured":"Sorimachi H, Ishiura S, Suzuki K. Structure and physiological function of calpains. Biochem J. 1997;328(Pt 3):721\u201332. (Pt 3)(.","journal-title":"Biochem J"},{"key":"4279_CR24","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/erm.2016.9","volume":"18","author":"I Toral-Ojeda","year":"2016","unstructured":"Toral-Ojeda I, Aldanondo G, Lasa-Elgarresta J, Lasa-Fern\u00e1ndez H, Fern\u00e1ndez-Torr\u00f3n R, de L\u00f3pez A, et al. Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle. Expert Rev Mol Med. 2016;18:e7.","journal-title":"Expert Rev Mol Med"},{"issue":"18","key":"4279_CR25","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.3390\/ijms20184548","volume":"20","author":"J Lasa-Elgarresta","year":"2019","unstructured":"Lasa-Elgarresta J, Mosqueira-Mart\u00edn L, Naldaiz-Gastesi N, S\u00e1enz A, L\u00f3pez de Munain A, Vallejo-Illarramendi A. Calcium Mechanisms in Limb-Girdle Muscular Dystrophy with CAPN3 Mutations. Int J Mol Sci. 2019;20(18):4548.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"4279_CR26","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1111\/j.1742-4658.2006.05351.x","volume":"273","author":"S Duguez","year":"2006","unstructured":"Duguez S, Bartoli M, Richard I. Calpain 3: a key regulator of the sarcomere? FEBS J. 2006;273(15):3427\u201336.","journal-title":"FEBS J"},{"issue":"12","key":"4279_CR27","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.nmd.2008.08.005","volume":"18","author":"JS Beckmann","year":"2008","unstructured":"Beckmann JS, Spencer M. Calpain 3, the \u2018gatekeeper\u2019 of proper sarcomere assembly, turnover and maintenance. Neuromuscul Disord. 2008;18(12):913\u201321.","journal-title":"Neuromuscul Disord"},{"issue":"17","key":"4279_CR28","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1093\/hmg\/ddp257","volume":"18","author":"I Kramerova","year":"2009","unstructured":"Kramerova I, Kudryashova E, Wu B, Germain S, Vandenborne K, Romain N, et al. Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle. Hum Mol Genet. 2009;18(17):3194\u2013205.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"4279_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/cells14060446","volume":"14","author":"A Valls","year":"2025","unstructured":"Valls A, Ruiz-Rold\u00e1n C, Immanuel J, Alonso-Mart\u00edn S, Gallardo E, Fern\u00e1ndez-Torr\u00f3n R, et al. The Role of Integrin \u03b21D Mislocalization in the Pathophysiology of Calpain 3-Related Limb-Girdle Muscular Dystrophy. Cells. 2025;14(6):446.","journal-title":"Cells"},{"key":"4279_CR30","unstructured":"Protocoles Nationaux de Diagnostic et de Soins (PNDS). [Internet]. Haute Autorit\u00e9 de Sant\u00e9. [cited 2025 Nov 24]. Available from: https:\/\/www.has-sante.fr\/jcms\/c_1340879\/fr\/protocoles-nationaux-de-diagnostic-et-de-soins-pnds"},{"issue":"5","key":"4279_CR31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1177\/22143602251345967","volume":"12","author":"SN Bardakov","year":"2025","unstructured":"Bardakov SN, Sorochanu I, Mkrtchyan LA, Slesarenko YS, Tsargush VA, Limaev IS, et al. Calpainopathy (limb-girdle muscular dystrophy type R1): clinical features, diagnostic approaches, and biotechnological treatment methods. J Neuromuscul Dis. 2025;12(5):594\u2013618.","journal-title":"J Neuromuscul Dis"},{"issue":"5","key":"4279_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.nmd.2021.02.012","volume":"31","author":"M Spinazzi","year":"2021","unstructured":"Spinazzi M, Poupiot J, Cassereau J, Leturcq F, Brunereau L, Malfatti E, et al. Late-onset camptocormia caused by a heterozygous in-frame CAPN3 deletion. Neuromuscul Disord. 2021;31(5):450\u20135.","journal-title":"Neuromuscul Disord"},{"issue":"16","key":"4279_CR33","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1212\/WNL.0b013e3181a1885e","volume":"72","author":"M Fanin","year":"2009","unstructured":"Fanin M, Nascimbeni AC, Aurino S, Tasca E, Pegoraro E, Nigro V, et al. Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes. Neurology. 2009;72(16):1432\u20135.","journal-title":"Neurology"},{"issue":"4","key":"4279_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5414\/NPP26157","volume":"26","author":"F Hanisch","year":"2007","unstructured":"Hanisch F, M\u00fcller CR, Grimm D, Xue L, Traufeller K, Merkenschlager A, et al. Frequency of calpain-3 c.550delA mutation in limb girdle muscular dystrophy type 2 and isolated hyperCKemia in German patients. Clin Neuropathol. 2007;26(4):157\u201363.","journal-title":"Clin Neuropathol"},{"issue":"1","key":"4279_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00415-019-09539-y","volume":"267","author":"A Barp","year":"2020","unstructured":"Barp A, Laforet P, Bello L, Tasca G, Vissing J, Monforte M, et al. European muscle MRI study in limb girdle muscular dystrophy type R1\/2A (LGMDR1\/LGMD2A). J Neurol. 2020;267(1):45\u201356.","journal-title":"J Neurol"},{"issue":"4","key":"4279_CR36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/mus.27686","volume":"66","author":"LU Aivazoglou","year":"2022","unstructured":"Aivazoglou LU, Guimar\u00e3es JB, Costa MAF, Aihara AY, Cardoso FN, Pinto WBVDR, et al. Whole-Body MRI in Limb Girdle Muscular Dystrophy Type R1\/2A: Correlation With Clinical Scores. Muscle Nerve. 2022;66(4):471\u20138.","journal-title":"Muscle Nerve"},{"key":"4279_CR37","doi-asserted-by":"crossref","unstructured":"Ilvnsjf C, V V, F C. Calpainopathy: Description of a novel mutation and clinical presentation with early severe contractures. Genes (Basel). 2020;11(2):E131. https:\/\/pubmed.ncbi.nlm.nih.gov\/31991774\/","DOI":"10.3390\/genes11020129"},{"key":"4279_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jns.2015.12.013","volume":"361","author":"R Lahoria","year":"2016","unstructured":"Lahoria R, Milone M. Rhabdomyolysis featuring muscular dystrophies. J Neurol Sci. 2016;361:29\u201333.","journal-title":"J Neurol Sci"},{"key":"4279_CR39","doi-asserted-by":"crossref","unstructured":"de Albuquerque MAV, Neto A, Silva O, Zanoteli FMA, Reed E. UC. Limb-girdle muscular dystrophy type 2A in Brazilian children. Arq Neuropsiquiatr. 2015;73(12):993\u20137.","DOI":"10.1590\/0004-282X20150168"},{"issue":"3","key":"4279_CR40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0960-8966(00)00197-8","volume":"11","author":"C Pollitt","year":"2001","unstructured":"Pollitt C, Anderson LV, Pogue R, Davison K, Pyle A, Bushby KM. The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach. Neuromuscul Disord. 2001;11(3):287\u201396.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"4279_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.nmd.2010.04.006","volume":"20","author":"G Burke","year":"2010","unstructured":"Burke G, Hillier C, Cole J, Sampson M, Bridges L, Bushby K, et al. Calpainopathy presenting as foot drop in a 41 year old. Neuromuscul Disord. 2010;20(6):407\u201310.","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"4279_CR42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.nmd.2005.03.004","volume":"15","author":"C B\u00e9rard","year":"2005","unstructured":"B\u00e9rard C, Payan C, Hodgkinson I, Fermanian J, MFM Collaborative Study Group. A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord. 2005;15(7):463\u201370.","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"4279_CR43","doi-asserted-by":"publisher","first-page":"pzac113","DOI":"10.1093\/ptj\/pzac113","volume":"102","author":"MK James","year":"2022","unstructured":"James MK, Alfano LN, Muni-Lofra R, Reash NF, Sodhi J, Iammarino MA, et al. Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies. Phys Ther. 2022;102(10):pzac113.","journal-title":"Phys Ther"},{"issue":"6","key":"4279_CR44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S1607-551X(09)70523-6","volume":"25","author":"Y Lue","year":"2009","unstructured":"Lue Y, Lin R, Chen S, Lu Y. Measurement of the Functional Status of Patients with Different Types of Muscular Dystrophy. Kaohsiung J Med Sci. 2009;25(6):325\u201333.","journal-title":"Kaohsiung J Med Sci"},{"key":"4279_CR45","unstructured":"Walton JN, Gardner-Medwin D, Edinburgh. 481\u2013524. - References - Scientific Research Publishing [Internet]. [cited 2025 Nov 24]. Available from: https:\/\/www.scirp.org\/reference\/referencespapers?referenceid=2102187"},{"issue":"1","key":"4279_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/JND-200547","volume":"8","author":"P Pathak","year":"2021","unstructured":"Pathak P, Sharma MC, Jha P, Sarkar C, Faruq M, Jha P, et al. Mutational Spectrum of CAPN3 with Genotype-Phenotype Correlations in Limb Girdle Muscular Dystrophy Type 2A\/R1 (LGMD2A\/LGMDR1) Patients in India. J Neuromuscul Dis. 2021;8(1):125\u201336.","journal-title":"J Neuromuscul Dis"},{"issue":"Pt 9","key":"4279_CR47","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1093\/brain\/121.9.1735","volume":"121","author":"M Urtasun","year":"1998","unstructured":"Urtasun M, S\u00e1enz A, Roudaut C, Poza JJ, Urtizberea JA, Cobo AM, et al. Limb-girdle muscular dystrophy in Guip\u00fazcoa (Basque Country, Spain). Brain. 1998;121(Pt 9):1735\u201347.","journal-title":"Brain"},{"key":"4279_CR48","doi-asserted-by":"publisher","unstructured":"Urinary N-. terminal titin fragment ascertained as biomarker in a small cohort of limb-girdle muscular dystrophy LGMDR1-calpain 3 related [Internet]. [cited 2026 Feb 6]. Available from: https:\/\/journals.sagepub.com\/doi\/epub\/https:\/\/doi.org\/10.1177\/22143602251323629","DOI":"10.1177\/22143602251323629"},{"issue":"2","key":"4279_CR49","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.nmd.2004.10.008","volume":"15","author":"E Mercuri","year":"2005","unstructured":"Mercuri E, Bushby K, Ricci E, Birchall D, Pane M, Kinali M, et al. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord. 2005;15(2):164\u201371.","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"4279_CR50","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00256-010-0930-4","volume":"39","author":"A Degardin","year":"2010","unstructured":"Degardin A, Morillon D, Lacour A, Cotten A, Vermersch P, Stojkovic T. Morphologic imaging in muscular dystrophies and inflammatory myopathies. Skeletal Radiol. 2010;39(12):1219\u201327.","journal-title":"Skeletal Radiol"},{"key":"4279_CR51","doi-asserted-by":"publisher","unstructured":"Malfatti E. The Role of the Muscle Biopsy in the Era of Genetic Diagnosis. In: Narayanaswami P, Liewluck T, editors. Principles and Practice of the Muscular Dystrophies [Internet]. Cham: Springer International Publishing; 2023 [cited 2025 Nov 12]. pp. 255\u201367. Available from: https:\/\/doi.org\/10.1007\/978-3-031-44009-0_16","DOI":"10.1007\/978-3-031-44009-0_16"},{"issue":"6","key":"4279_CR52","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/ana.20900","volume":"59","author":"RH Brown","year":"2006","unstructured":"Brown RH, Amato A. Calpainopathy and eosinophilic myositis. Ann Neurol. 2006;59(6):875\u20137.","journal-title":"Ann Neurol"},{"issue":"6","key":"4279_CR53","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/ana.20833","volume":"59","author":"M Krahn","year":"2006","unstructured":"Krahn M, Lopez de Munain A, Streichenberger N, Bernard R, P\u00e9cheux C, Testard H, et al. CAPN3 mutations in patients with idiopathic eosinophilic myositis. Ann Neurol. 2006;59(6):905\u201311.","journal-title":"Ann Neurol"},{"issue":"4","key":"4279_CR54","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1399-0004.2010.01620.x","volume":"80","author":"M Krahn","year":"2011","unstructured":"Krahn M, Goicoechea M, Hanisch F, Groen E, Bartoli M, P\u00e9cheux C, et al. Eosinophilic infiltration related to CAPN3 mutations: a pathophysiological component of primary calpainopathy? Clin Genet. 2011;80(4):398\u2013402.","journal-title":"Clin Genet"},{"issue":"8","key":"4279_CR55","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0960-8966(00)00143-7","volume":"10","author":"LV Anderson","year":"2000","unstructured":"Anderson LV, Harrison RM, Pogue R, Vafiadaki E, Pollitt C, Davison K, et al. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord. 2000;10(8):553\u20139.","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"4279_CR56","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1212\/WNL.56.7.869","volume":"56","author":"H Haravuori","year":"2001","unstructured":"Haravuori H, Vihola A, Straub V, Auranen M, Richard I, Marchand S, et al. Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology. 2001;56(7):869\u201377.","journal-title":"Neurology"},{"issue":"2","key":"4279_CR57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.nmd.2006.11.001","volume":"17","author":"A Milic","year":"2007","unstructured":"Milic A, Daniele N, Lochm\u00fcller H, Mora M, Comi GP, Moggio M, et al. A third of LGMD2A biopsies have normal calpain 3 proteolytic activity as determined by an in vitro assay. Neuromuscul Disord. 2007;17(2):148\u201356.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"4279_CR58","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0002-9440(10)63551-1","volume":"163","author":"M Fanin","year":"2003","unstructured":"Fanin M, Nascimbeni AC, Fulizio L, Trevisan CP, Meznaric-Petrusa M, Angelini C. Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression. Am J Pathol. 2003;163(5):1929\u201336.","journal-title":"Am J Pathol"},{"issue":"18","key":"4279_CR59","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.3390\/jcm12186011","volume":"12","author":"C Bouchard","year":"2023","unstructured":"Bouchard C, Tremblay JP. Portrait of Dysferlinopathy: Diagnosis and Development of Therapy. J Clin Med. 2023;12(18):6011.","journal-title":"J Clin Med"},{"issue":"10","key":"4279_CR60","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1136\/jnnp-2017-317488","volume":"89","author":"J Diaz-Manera","year":"2018","unstructured":"Diaz-Manera J, Fernandez-Torron R, LLauger J, James MK, Mayhew A, Smith FE, et al. Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials. J Neurol Neurosurg Psychiatry. 2018;89(10):1071\u201381.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4279_CR61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1051\/medsci\/2020239","volume":"36","author":"RN Villar Quiles","year":"2020","unstructured":"Villar Quiles RN, Richard I, Bouchet-Seraphin C, Stojkovic T. [Limb-Girdle Muscular Dystrophy type R9 linked to the FKRP gene: state of the art and therapeutic perspectives]. Med Sci (Paris). 2020;36:2:28\u201333. Hors s\u00e9rie n\u00b0.","journal-title":"Med Sci (Paris)"},{"key":"4279_CR62","doi-asserted-by":"publisher","first-page":"3710814","DOI":"10.1155\/2018\/3710814","volume":"2018","author":"Z Xie","year":"2018","unstructured":"Xie Z, Xiao J, Zheng Y, Wang Z, Yuan Y. Magnetic Resonance Imaging Findings in the Muscle Tissue of Patients with Limb Girdle Muscular Dystrophy Type 2I Harboring the Founder Mutation c.545A\u2009>\u2009G in the FKRP Gene. Biomed Res Int. 2018;2018:3710814.","journal-title":"Biomed Res Int"},{"issue":"4","key":"4279_CR63","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3233\/JND-200515","volume":"7","author":"J V\u00e1zquez","year":"2020","unstructured":"V\u00e1zquez J, Lefeuvre C, Escobar RE, Luna Angulo AB, Miranda Duarte A, Delia Hernandez A, et al. Phenotypic Spectrum of Myopathies with Recessive Anoctamin-5 Mutations. J Neuromuscul Dis. 2020;7(4):443\u201351.","journal-title":"J Neuromuscul Dis"},{"issue":"9","key":"4279_CR64","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1093\/brain\/awad088","volume":"146","author":"A de Bruyn","year":"2023","unstructured":"de Bruyn A, Montagnese F, Holm-Yildiz S, Scharff Poulsen N, Stojkovic T, Behin A, et al. Anoctamin-5 related muscle disease: clinical and genetic findings in a large European cohort. Brain. 2023;146(9):3800\u201315.","journal-title":"Brain"},{"issue":"10","key":"4279_CR65","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.nmd.2021.07.014","volume":"31","author":"M Vainzof","year":"2021","unstructured":"Vainzof M, Souza LS, Gurgel-Giannetti J, Zatz M. Sarcoglycanopathies: an update. Neuromuscul Disord. 2021;31(10):1021\u20137.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"4279_CR66","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/jnnp-2017-316736","volume":"89","author":"G Tasca","year":"2018","unstructured":"Tasca G, Monforte M, D\u00edaz-Manera J, Brisca G, Semplicini C, D\u2019Amico A, et al. MRI in sarcoglycanopathies: a large international cohort study. J Neurol Neurosurg Psychiatry. 2018;89(1):72\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"4279_CR67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/jmedgenet-2011-100101","volume":"49","author":"S Sacconi","year":"2012","unstructured":"Sacconi S, Cama\u00f1o P, de Greef JC, Lemmers RJLF, Salviati L, Boileau P, et al. Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity. J Med Genet. 2012;49(1):41\u20136.","journal-title":"J Med Genet"},{"key":"4279_CR68","unstructured":"Darras BT, Urion DK, Ghosh PS. Dystrophinopathies. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2025 Nov 27]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1119\/"},{"issue":"9","key":"4279_CR69","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1212\/WNL.41.9.1491","volume":"41","author":"E Arikawa","year":"1991","unstructured":"Arikawa E, Hoffman EP, Kaido M, Nonaka I, Sugita H, Arahata K. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population. Neurology. 1991;41(9):1491\u20136.","journal-title":"Neurology"},{"issue":"2","key":"4279_CR70","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/practneurol-2014-000992","volume":"15","author":"G Shaboodien","year":"2015","unstructured":"Shaboodien G, Watkins DA, Pillay K, Beighton P, Heckmann JM, Mayosi BM. Limb-girdle weakness in a marfanoid man: distinguishing calpainopathy from Becker\u2019s muscular dystrophy. Pract Neurol. 2015;15(2):152\u20134.","journal-title":"Pract Neurol"},{"issue":"8","key":"4279_CR71","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/(SICI)1097-4598(199808)21:8<1078::AID-MUS15>3.0.CO;2-Q","volume":"21","author":"I P\u00e9nisson-Besnier","year":"1998","unstructured":"P\u00e9nisson-Besnier I, Richard I, Dubas F, Beckmann JS, Fardeau M. Pseudometabolic expression and phenotypic variability of calpain deficiency in two siblings. Muscle Nerve. 1998;21(8):1078\u201380.","journal-title":"Muscle Nerve"},{"issue":"3","key":"4279_CR72","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41431-018-0305-1","volume":"27","author":"M Krahn","year":"2019","unstructured":"Krahn M, Biancalana V, Cerino M, Perrin A, Michel-Calemard L, Nectoux J, et al. A National French consensus on gene lists for the diagnosis of myopathies using next-generation sequencing. Eur J Hum Genet. 2019;27(3):349\u201352.","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"4279_CR73","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1001\/jamaneurol.2015.2274","volume":"72","author":"R Ghaoui","year":"2015","unstructured":"Ghaoui R, Cooper ST, Lek M, Jones K, Corbett A, Reddel SW, et al. Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy: Outcomes and Lessons Learned. JAMA Neurol. 2015;72(12):1424\u201332.","journal-title":"JAMA Neurol"},{"issue":"Pt 1","key":"4279_CR74","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/brain\/119.1.295","volume":"119","author":"M Fardeau","year":"1996","unstructured":"Fardeau M, Hillaire D, Mignard C, Feingold N, Feingold J, Mignard D, et al. Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain. 1996;119(Pt 1):295\u2013308.","journal-title":"Brain"},{"issue":"5","key":"4279_CR75","first-page":"1128","volume":"60","author":"I Richard","year":"1997","unstructured":"Richard I, Brenguier L, Din\u00e7er P, Roudaut C, Bady B, Burgunder JM, et al. Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins. Am J Hum Genet. 1997;60(5):1128\u201338.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"4279_CR76","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0960-8966(96)00387-2","volume":"6","author":"M Fardeau","year":"1996","unstructured":"Fardeau M, Eymard B, Mignard C, Tom\u00e9 FM, Richard I, Beckmann JS. Chromosome 15-linked limb-girdle muscular dystrophy: clinical phenotypes in Reunion Island and French metropolitan communities. Neuromuscul Disord. 1996;6(6):447\u201353.","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"4279_CR77","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/j.1468-1331.2007.01979.x","volume":"14","author":"F Norwood","year":"2007","unstructured":"Norwood F, de Visser M, Eymard B, Lochm\u00fcller H, Bushby K, EFNS Guideline Task Force. EFNS guideline on diagnosis and management of limb girdle muscular dystrophies. Eur J Neurol. 2007;14(12):1305\u201312.","journal-title":"Eur J Neurol"},{"issue":"1","key":"4279_CR78","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1179\/174313209X380847","volume":"32","author":"C Angelini","year":"2010","unstructured":"Angelini C, Nardetto L, Borsato C, Padoan R, Fanin M, Nascimbeni AC, et al. The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B). Neurol Res. 2010;32(1):41\u20136.","journal-title":"Neurol Res"},{"issue":"7\u20138","key":"4279_CR79","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0960-8966(03)00100-7","volume":"13","author":"M Zatz","year":"2003","unstructured":"Zatz M, de Paula F, Starling A, Vainzof M. The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord. 2003;13(7\u20138):532\u201344.","journal-title":"Neuromuscul Disord"},{"key":"4279_CR80","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/B978-0-08-045031-5.00006-2","volume":"101","author":"E Gallardo","year":"2011","unstructured":"Gallardo E, Saenz A, Illa I. Limb-girdle muscular dystrophy 2A. Handb Clin Neurol. 2011;101:97\u2013110.","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"4279_CR81","doi-asserted-by":"publisher","first-page":"179","DOI":"10.5414\/NP300728","volume":"33","author":"M Fanin","year":"2014","unstructured":"Fanin M, Nascimbeni AC, Angelini C. Gender difference in limb-girdle muscular dystrophy: a muscle fiber morphometric study in 101 patients. Clin Neuropathol. 2014;33(3):179\u201385.","journal-title":"Clin Neuropathol"},{"issue":"9","key":"4279_CR82","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/jmg.2004.028738","volume":"42","author":"G Piluso","year":"2005","unstructured":"Piluso G, Politano L, Aurino S, Fanin M, Ricci E, Ventriglia VM, et al. Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes. J Med Genet. 2005;42(9):686\u201393.","journal-title":"J Med Genet"},{"issue":"10","key":"4279_CR83","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/PHM.0000000000001204","volume":"98","author":"KL Bennell","year":"2019","unstructured":"Bennell KL, Marshall CJ, Dobson F, Kasza J, Lonsdale C, Hinman RS. Does a Web-Based Exercise Programming System Improve Home Exercise Adherence for People With Musculoskeletal Conditions? A Randomized Controlled Trial. Am J Phys Med Rehabil. 2019;98(10):850\u20138.","journal-title":"Am J Phys Med Rehabil"},{"issue":"1","key":"4279_CR84","first-page":"3","volume":"34","author":"G Siciliano","year":"2015","unstructured":"Siciliano G, Simoncini C, Giannotti S, Zampa V, Angelini C, Ricci G. Muscle exercise in limb girdle muscular dystrophies: pitfall and advantages. Acta Myol. 2015;34(1):3\u20138.","journal-title":"Acta Myol"},{"issue":"4","key":"4279_CR85","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/mus.25369","volume":"55","author":"M Mori-Yoshimura","year":"2017","unstructured":"Mori-Yoshimura M, Segawa K, Minami N, Oya Y, Komaki H, Nonaka I, et al. Cardiopulmonary dysfunction in patients with limb-girdle muscular dystrophy 2A. Muscle Nerve. 2017;55(4):465\u20139.","journal-title":"Muscle Nerve"},{"issue":"3","key":"4279_CR86","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0887-8994(00)00262-9","volume":"24","author":"E Dirik","year":"2001","unstructured":"Dirik E, Aydin A, Kurul S, Sahin B. Limb girdle muscular dystrophy type 2A presenting with cardiac arrest. Pediatr Neurol. 2001;24(3):235\u20137.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"4279_CR87","first-page":"244","volume":"82","author":"EL De Vito","year":"2022","unstructured":"De Vito EL. [When should and when should not use oxygen in neuromuscular diseases?]. Med (B Aires). 2022;82(2):244\u20138.","journal-title":"Med (B Aires)"},{"issue":"4","key":"4279_CR88","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4065\/70.4.403","volume":"70","author":"MJ Tobin","year":"1995","unstructured":"Tobin MJ, Jubran A. Oxygen takes the breath away: old sting, new setting. Mayo Clin Proc. 1995;70(4):403\u20134.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"4279_CR89","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41591-024-03304-z","volume":"31","author":"JR Mendell","year":"2025","unstructured":"Mendell JR, Muntoni F, McDonald CM, Mercuri EM, Ciafaloni E, Komaki H, et al. AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial. Nat Med. 2025;31(1):332\u201341.","journal-title":"Nat Med"},{"issue":"2","key":"4279_CR90","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ymthe.2005.09.017","volume":"13","author":"M Bartoli","year":"2006","unstructured":"Bartoli M, Roudaut C, Martin S, Fougerousse F, Suel L, Poupiot J, et al. Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A. Mol Ther. 2006;13(2):250\u20139.","journal-title":"Mol Ther"},{"issue":"10","key":"4279_CR91","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCULATIONAHA.113.001340","volume":"128","author":"C Roudaut","year":"2013","unstructured":"Roudaut C, Le Roy F, Suel L, Poupiot J, Charton K, Bartoli M, et al. Restriction of calpain3 expression to the skeletal muscle prevents cardiac toxicity and corrects pathology in a murine model of limb-girdle muscular dystrophy. Circulation. 2013;128(10):1094\u2013104.","journal-title":"Circulation"},{"issue":"520","key":"4279_CR92","doi-asserted-by":"publisher","first-page":"eaat6072","DOI":"10.1126\/scitranslmed.aat6072","volume":"11","author":"W Lostal","year":"2019","unstructured":"Lostal W, Roudaut C, Faivre M, Charton K, Suel L, Bourg N, et al. Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A. Sci Transl Med. 2019;11(520):eaat6072.","journal-title":"Sci Transl Med"},{"key":"4279_CR93","doi-asserted-by":"publisher","first-page":"101147","DOI":"10.1016\/j.omtm.2023.101147","volume":"31","author":"J Shoti","year":"2023","unstructured":"Shoti J, Qing K, Keeler GD, Duan D, Byrne BJ, Srivastava A. Development of capsid- and genome-modified optimized AAVrh74 vectors for muscle gene therapy. Mol Ther Methods Clin Dev. 2023;31:101147.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4279_CR94","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.omtn.2023.02.005","volume":"31","author":"S M\u00fcthel","year":"2023","unstructured":"M\u00fcthel S, Marg A, Ignak B, Kieshauer J, Escobar H, Stadelmann C, et al. Cas9-induced single cut enables highly efficient and template-free repair of a muscular dystrophy causing founder mutation. Mol Ther Nucleic Acids. 2023;31:494\u2013511.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4279_CR95","doi-asserted-by":"publisher","first-page":"822563","DOI":"10.3389\/fcell.2022.822563","volume":"10","author":"J Lasa-Elgarresta","year":"2022","unstructured":"Lasa-Elgarresta J, Mosqueira-Mart\u00edn L, Gonz\u00e1lez-Imaz K, Marco-Moreno P, Gerenu G, Mamchaoui K, et al. Targeting the Ubiquitin-Proteasome System in Limb-Girdle Muscular Dystrophy With CAPN3 Mutations. Front Cell Dev Biol. 2022;10:822563.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4279_CR96","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13395-020-00254-1","volume":"10","author":"VE Jahnke","year":"2020","unstructured":"Jahnke VE, Peterson JM, Van Der Meulen JH, Boehler J, Uaesoontrachoon K, Johnston HK, et al. Mitochondrial dysfunction and consequences in calpain-3-deficient muscle. Skelet Muscle. 2020;10(1):37.","journal-title":"Skelet Muscle"},{"issue":"14","key":"4279_CR97","doi-asserted-by":"publisher","first-page":"7367","DOI":"10.3390\/ijms22147367","volume":"22","author":"A Rico","year":"2021","unstructured":"Rico A, Guembelzu G, Palomo V, Mart\u00ednez A, Aiastui A, Casas-Fraile L, et al. Allosteric Modulation of GSK-3\u03b2 as a New Therapeutic Approach in Limb Girdle Muscular Dystrophy R1 Calpain 3-Related. Int J Mol Sci. 2021;22(14):7367.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"4279_CR98","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1111\/bph.70017","volume":"182","author":"C Bruge","year":"2025","unstructured":"Bruge C, Bourg N, Pellier E, Tournois J, Polentes J, Benabides M, et al. High-throughput screening identifies bazedoxifene as a potential therapeutic for dysferlin-deficient limb girdle muscular dystrophy. Br J Pharmacol. 2025;182(13):2930\u201349.","journal-title":"Br J Pharmacol"},{"key":"4279_CR99","doi-asserted-by":"publisher","first-page":"856804","DOI":"10.3389\/fphar.2022.856804","volume":"13","author":"L Hoch","year":"2022","unstructured":"Hoch L, Bourg N, Degrugillier F, Bruge C, Benabides M, Pellier E, et al. Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination. Front Pharmacol. 2022;13:856804.","journal-title":"Front Pharmacol"},{"issue":"5","key":"4279_CR100","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ana.21338","volume":"63","author":"KR Wagner","year":"2008","unstructured":"Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, et al. A phase I\/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol. 2008;63(5):561\u201371.","journal-title":"Ann Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04279-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04279-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04279-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:02:12Z","timestamp":1781636532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04279-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4279"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04279-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This review did not involve any primary research with human participants or animals. Therefore, ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}},{"value":"Not applicable. This review did not involve any primary research with human participants. Therefore, consent to participate was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable. This review does not contain any individual identifiable data. Therefore, consent for publication was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}